Younes Belkouchi
Gif-sur-yvette, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scans.
Journal: Frontiers in oncology
Published: August 17, 2025
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients.
Journal: Future oncology (London, England)
Published: February 10, 2025
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 24, 2024
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
Journal: Journal for immunotherapy of cancer
Published: August 14, 2023
Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution.
Journal: Diagnostic and interventional imaging
Published: August 08, 2023
Detection and quantification of pulmonary embolism with artificial intelligence: The SFR 2022 artificial intelligence data challenge.
Journal: Diagnostic and interventional imaging
Published: May 25, 2023
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs.
Journal: Diagnostics (Basel, Switzerland)
Published: November 29, 2022
Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks.
Journal: Diagnostic and interventional imaging
Published: October 20, 2022
Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge.
Journal: Diagnostic and interventional imaging
Published: September 19, 2022
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume.
Journal: Frontiers in oncology
Published: June 30, 2022
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 21, 2022
Last Updated: 09/26/2026